The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Zoonotic Disease Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Zoonotic Disease is directly transmitted from animals to humans through media such as air (influenza) or through bites and saliva (rabies).
The global Zoonotic Disease Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Zoonotic Disease Treatment in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Zoonotic Disease Treatment market. Viral Hepatitis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Rabies segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 21%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Zoonotic Disease Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Zoonotic Disease Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Zoonotic Disease Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Zoonotic Disease Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Zoonotic Disease Treatment covered in this report include Sanofi, Novartis, Pfizer, Johnson & Johnson, GlaxoSmithKline, Roche, AstraZeneca, BioCryst and AstraZeneca, etc.
The global Zoonotic Disease Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Novartis
Pfizer
Johnson & Johnson
GlaxoSmithKline
Roche
AstraZeneca
BioCryst
AstraZeneca
Global Zoonotic Disease Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Zoonotic Disease Treatment market, Segment by Type:
Viral Hepatitis
Rabies
Relapsing Fever
Tuberculosis
Malaria
Others
Global Zoonotic Disease Treatment market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Zoonotic Disease Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Zoonotic Disease is directly transmitted from animals to humans through media such as air (influenza) or through bites and saliva (rabies).
The global Zoonotic Disease Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Zoonotic Disease Treatment in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Zoonotic Disease Treatment market. Viral Hepatitis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Rabies segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 21%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Zoonotic Disease Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Zoonotic Disease Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Zoonotic Disease Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Zoonotic Disease Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Zoonotic Disease Treatment covered in this report include Sanofi, Novartis, Pfizer, Johnson & Johnson, GlaxoSmithKline, Roche, AstraZeneca, BioCryst and AstraZeneca, etc.
The global Zoonotic Disease Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Novartis
Pfizer
Johnson & Johnson
GlaxoSmithKline
Roche
AstraZeneca
BioCryst
AstraZeneca
Global Zoonotic Disease Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Zoonotic Disease Treatment market, Segment by Type:
Viral Hepatitis
Rabies
Relapsing Fever
Tuberculosis
Malaria
Others
Global Zoonotic Disease Treatment market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Zoonotic Disease Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Zoonotic Disease Treatment
1.1 Zoonotic Disease Treatment Market Overview
1.1.1 Zoonotic Disease Treatment Product Scope
1.1.2 Zoonotic Disease Treatment Market Status and Outlook
1.2 Global Zoonotic Disease Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Zoonotic Disease Treatment Market Size by Region (2018-2029)
1.4 Global Zoonotic Disease Treatment Historic Market Size by Region (2018-2023)
1.5 Global Zoonotic Disease Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Zoonotic Disease Treatment Market Size (2018-2029)
1.6.1 North America Zoonotic Disease Treatment Market Size (2018-2029)
1.6.2 Europe Zoonotic Disease Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Zoonotic Disease Treatment Market Size (2018-2029)
1.6.4 Latin America Zoonotic Disease Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Zoonotic Disease Treatment Market Size (2018-2029)
2 Zoonotic Disease Treatment Market by Type
2.1 Introduction
2.1.1 Viral Hepatitis
2.1.2 Rabies
2.1.3 Relapsing Fever
2.1.4 Tuberculosis
2.1.5 Malaria
2.1.6 Others
2.2 Global Zoonotic Disease Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Zoonotic Disease Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Zoonotic Disease Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Zoonotic Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Zoonotic Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Zoonotic Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Zoonotic Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Zoonotic Disease Treatment Revenue Breakdown by Type (2018-2029)
3 Zoonotic Disease Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.2 Global Zoonotic Disease Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Zoonotic Disease Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Zoonotic Disease Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Zoonotic Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Zoonotic Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Zoonotic Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Zoonotic Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Zoonotic Disease Treatment Revenue Breakdown by Application (2018-2029)
4 Zoonotic Disease Treatment Competition Analysis by Players
4.1 Global Zoonotic Disease Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Zoonotic Disease Treatment as of 2022)
4.3 Date of Key Players Enter into Zoonotic Disease Treatment Market
4.4 Global Top Players Zoonotic Disease Treatment Headquarters and Area Served
4.5 Key Players Zoonotic Disease Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Zoonotic Disease Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi Zoonotic Disease Treatment Products, Services and Solutions
5.1.4 Sanofi Zoonotic Disease Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Sanofi Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Zoonotic Disease Treatment Products, Services and Solutions
5.2.4 Novartis Zoonotic Disease Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Zoonotic Disease Treatment Products, Services and Solutions
5.3.4 Pfizer Zoonotic Disease Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Johnson & Johnson Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Profile
5.4.2 Johnson & Johnson Main Business
5.4.3 Johnson & Johnson Zoonotic Disease Treatment Products, Services and Solutions
5.4.4 Johnson & Johnson Zoonotic Disease Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Johnson & Johnson Recent Developments
5.5 GlaxoSmithKline
5.5.1 GlaxoSmithKline Profile
5.5.2 GlaxoSmithKline Main Business
5.5.3 GlaxoSmithKline Zoonotic Disease Treatment Products, Services and Solutions
5.5.4 GlaxoSmithKline Zoonotic Disease Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 GlaxoSmithKline Recent Developments
5.6 Roche
5.6.1 Roche Profile
5.6.2 Roche Main Business
5.6.3 Roche Zoonotic Disease Treatment Products, Services and Solutions
5.6.4 Roche Zoonotic Disease Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Roche Recent Developments
5.7 AstraZeneca
5.7.1 AstraZeneca Profile
5.7.2 AstraZeneca Main Business
5.7.3 AstraZeneca Zoonotic Disease Treatment Products, Services and Solutions
5.7.4 AstraZeneca Zoonotic Disease Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 AstraZeneca Recent Developments
5.8 BioCryst
5.8.1 BioCryst Profile
5.8.2 BioCryst Main Business
5.8.3 BioCryst Zoonotic Disease Treatment Products, Services and Solutions
5.8.4 BioCryst Zoonotic Disease Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 BioCryst Recent Developments
5.9 AstraZeneca
5.9.1 AstraZeneca Profile
5.9.2 AstraZeneca Main Business
5.9.3 AstraZeneca Zoonotic Disease Treatment Products, Services and Solutions
5.9.4 AstraZeneca Zoonotic Disease Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 AstraZeneca Recent Developments
6 North America
6.1 North America Zoonotic Disease Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Zoonotic Disease Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Zoonotic Disease Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Zoonotic Disease Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Zoonotic Disease Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Zoonotic Disease Treatment Market Dynamics
11.1 Zoonotic Disease Treatment Industry Trends
11.2 Zoonotic Disease Treatment Market Drivers
11.3 Zoonotic Disease Treatment Market Challenges
11.4 Zoonotic Disease Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
